epitalon or epithalon peptide scientific studies clinical trials telomere EPITALON Peptide Therapy in Connecticut

After preliminary functional screening (see below), N-hexanoic-Tyr-Ile-(6)amino-hexanoic amide was chosen for further investigation with the expectation that it would be biologically active, metabolically stable, and BBB permeable

Once they become too short, cells can no longer divide efficiently, leading to diminished repair capacity and the gradual onset of aging

This age-related decline is not merely inconvenient

PanDDA analysis of the 981 processable datasets resulted in 50 hits being identified across different sites of the protein, 28 of which were found in the TIN2 TBM binding site (Fig

10.1016/j.biomaterials.2019.119491 3

Body composition may influence dosing requirements, though weight-based dosing has not been consistently employed in animal studies or limited human applications